Michelle Trachtenberg Died Of Complications From This Common Condition
Fans were shocked when, on February 26, news broke that actor Michelle Trachtenberg, 39, had been found dead in her New York City apartment. At the time, the reason for the Gossip Girl alum's death wasn't known. Now, her official cause of death has been revealed as complications of diabetes mellitus, according to People.
Michelle's family objected to an autopsy for religious reasons, per ABC News, and as a result, the medical examiner limited the investigation to an external exam and lab testing.
Sources previously told People that Michelle had a liver transplant months before her death and may have had complications. Another source told the magazine that Michelle had been 'really, really down emotionally' and had told her friends that she was 'struggling' in the year before her death.
But Michelle's official cause of death is now raising more questions. Here's what you need to know.
Meet the expert: Mir Ali, MD, general surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA
Michelle died of complications of diabetes mellitus, better known as diabetes, according to People. Her cause of death has been ruled as natural, a spokesperson for the New York City Office of Chief Medical Examiner said.
Nearly 30 million Americans have diabetes, and it is the eighth largest cause of death in the U.S., leading to 101,209 deaths each year, according to the Centers for Disease Control and Prevention (CDC).
However, it's not common to die from diabetes complications, says Mir Ali, MD, general surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, California.
There are a few ways someone can die from diabetes complications, Ali (who did not treat Michelle) says. 'You can die from having your blood sugar be too low,' he says. 'You can become unconscious and, if it's not treated promptly, you can die from that.'
But it's also possible to die from having blood sugar that's too high, he says. This can lead to complications like diabetic ketoacidosis, which can cause someone to slip into a coma and die, per the CDC. (This is more common in people with type 1 diabetes.)
But while it's possible to die from complications of diabetes, Ali says that the average patient shouldn't stress about this, especially if their blood sugar is well managed. 'Sudden death, strictly from diabetes, is very uncommon,' he says.
You Might Also Like
Jennifer Garner Swears By This Retinol Eye Cream
These New Kicks Will Help You Smash Your Cross-Training Goals
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Politico
38 minutes ago
- Politico
RFK Jr. guts ACIP. What happens next?
Presented by Driving the day ACIP FIRINGS ROCK WASHINGTON — HHS Secretary Robert F. Kennedy Jr. abruptly removed 17 vaccine experts from the CDC's Advisory Committee on Immunization Practices on Monday — and Washington is already reeling. 'The committee has been plagued with persistent conflicts of interest and has become little more than a rubber stamp for any vaccine,' Kennedy wrote in an opinion piece published in The Wall Street Journal. He wrote that the decision is meant to restore faith in vaccines. Public health experts and Democrats immediately condemned the action — which POLITICO reported was under consideration in February. 'This is absolutely unprecedented. RFK Jr. has many levers at his disposal to influence vaccine policy in the U.S., each with varying degrees of impact. But this move is a red-alert, level 4 alarm,' said Katelyn Jetelina, an epidemiologist who's consulted for the CDC. The biopharmaceutical industry also raised concerns. 'A wholesale change of this manner will negatively affect the Committee's ability to deliberate and make well-informed recommendations, putting American lives at risk,' Biotechnology Innovation Organization CEO John Crowley said in a statement. 'We agree that transparency is key to restoring trust in immunizations; however, the actions taken today upend a time-tested system that has protected American public health.' The removal of the experts also appears to buck the commitment Kennedy made to Senate Health, Education, Labor and Pensions Chair Bill Cassidy (R-La.) to 'maintain' the committee 'without changes.' But Cassidy told reporters at the U.S. Capitol that he spoke with Kennedy twice Monday and that the assurance he'd won from the now-secretary concerned ACIP's structure rather than membership. 'Of course, now the fear is that the ACIP will be filled up with people who know nothing about vaccines except suspicion,' Cassidy posted on X after the announcement. That fear was echoed by Democrats — who slammed the decision as a dangerous action that puts the health of Americans at risk. 'Secretary Kennedy is firing the 17 medical experts that advise our nation on immunization practices so he can stack the panel with a bunch of anti-vaccine wackos,' House Energy and Commerce ranking member Frank Pallone (D-N.J.) said in a statement. Remember: FDA Commissioner Marty Makary slammed ACIP as a 'kangaroo court' earlier this month on CBS' 'Face the Nation.' What's next: HHS said ACIP will still meet June 25-27, but with new membership. IT'S TUESDAY. WELCOME BACK TO PRESCRIPTION PULSE. Do you know how the decision to fire ACIP members went down? Send your tips to David Lim (dlim@ @davidalim or davidalim.49 on Signal) and Lauren Gardner (lgardner@ @Gardner_LM or gardnerlm.01 on Signal). Eye on the FDA DECISION TIME ON RSV — Two drug products targeting respiratory syncytial virus — a common bug that can cause severe illness in young babies and older adults — are on deck FDA decisions this week. Another antibody: The agency approved Merck's preventive monoclonal antibody Monday — a day ahead of schedule — for infants' first RSV season, injecting more competition into the RSV market. The company has designed the drug, dubbed Enflonsia, to be the same single dose administered to babies of any weight — a departure from Sanofi's Beyfortus, which is made in different dosage amounts depending on a baby or toddler's age and weight. Dr. Octavio Ramilo of St. Jude Children's Research Hospital, who worked as an investigator for Merck's trials for the drug, said its 'dosing convenience' and strong evidence showing reductions in disease and hospitalization make Enflonsia 'a promising new intervention to help protect infants from RSV.' Merck said it expects the CDC's external vaccine panel to make recommendations for the antibody's use at its next meeting in late June. The company statement came out just before HHS Secretary Robert F. Kennedy Jr.'s op-ed on the Advisory Committee on Immunization Practices was published. Another vaccine? Moderna is slated to get a decision on its mRNA vaccine for RSV in high-risk adults under 60 by Thursday. The FDA approved mResvia last year for adults 60 and older, and the company has said the shot met its study goals in the younger population. But Kennedy's suspicion of mRNA technology has prompted the federal government to pull funding from Moderna's bird flu vaccine program and to condition future Covid vaccine approvals for healthy people on more data, making the FDA's decision this week worth watching. Moderna stopped working on a version of the vaccine for children last year after receiving reports of severe lower respiratory tract infections in immunized trial participants. In Congress IN THE HOT SEAT — President Donald Trump's cuts to ideologically disfavored research have left the National Institutes of Health with unspent funds. Director Jay Bhattacharya, under pressure from critics on Capitol Hill and in the research community, is pledging to change that. But Democrats will get a chance to ask Bhattacharya for more details when he testifies before a Senate Appropriations subcommittee this morning. Pharma Moves Dr. Jennifer Peña is joining women's telehealth company Wisp as chief medical officer. She previously worked in similar roles at Oscar Health and Nurx and served as a White House physician under Barack Obama and Donald Trump. Document Drawer The FDA is publicizing a voluntary recall by Church & Dwight Co. of its Zicam nasal swabs and Orajel baby teething swabs due to potential fungi microbial contamination in the cotton swab components. No serious adverse events have been reported to date. The White House Office of Information and Regulatory Affairs is reviewing a 340B rebate guidance from the Health Resources and Services Administration. WHAT WE'RE READING STAT's Helen Branswell examines efforts by philanthropic leaders to maintain a network of labs that conduct surveillance of measles and rubella around the world following cuts by the Trump administration to global aid dollars. A bipartisan bill that tackles tools Medicare Advantage plans use to get higher payments from the federal government could be included in Senate Republicans' megabill, but a key Democrat doesn't want it in the package, POLITICO's Robert King and Meredith Lee Hill report. Nearly 50 food industry groups and companies are being invited by the White House to discuss a recent report on its Make America Healthy Again goals, POLITICO's Grace Yarrow reports.
Newsweek
44 minutes ago
- Newsweek
Quadruple Rise in Uncommon Cancer Seen in Older Millennials
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A new study has found a striking increase in appendix cancer in Americans born after 1945, with older millennials experiencing the most dramatic rise. Appendix cancer, according to the National Cancer Institute, is fortunately very rare, affecting only about 1–2 people in every million annually. However, the study led by researchers at Vanderbilt University Medical Center in Nashville, Tennessee, found that appendiceal adenocarcinoma (AA) diagnoses have more than tripled in those born around 1980 and quadrupled in those born around 1985. While older millennials were those with the highest number of diagnoses, researchers believe that as higher-risk birth cohorts continue to age, it is likely that AA incidence rates will increase in the future. The study was based on data from the National Cancer Institute SEER (Surveillance, Epidemiology, and End Results) Program, with the researchers analyzing the incidence of AA in people aged 20 or older from 1975 to 2019. In total, they examined 4,858 confirmed cases. A stock image shows a doctor pressing on a young woman's appendix. A stock image shows a doctor pressing on a young woman's appendix. getty images According to the Cleveland Clinic, sex and age are risk factors for appendix cancer; women are more likely to develop AA, are are those aged 50 and over. Other factors include smoking, a family history of cancer and health conditions such as atrophic gastritis (where the stomach lining becomes chronically inflamed), pernicious anemia (an autoimmune condition which affects the red blood cells) and Zollinger–Ellison syndrome (in which tumors cause ulcers in the stomach and upper small intestine), which have all been linked to a higher risk. Symptoms of appendix cancer vary from person to person—and sometimes can be asymptomatic. When present, symptoms usually include appendicitis, bloating, fluid buildup in the abdomen, increase in waist size, pain in the abdomen or pelvis, changes in bowel habits, nausea, vomiting and a tendency to feel full. According to the Centers for Disease Control and Prevention (CDC), risk factors for cancer in general include alcohol usage, HPV and obesity, which is associated with a higher risk of 13 types of cancer. These include adenocarcinoma of the esophagus, breast, colon/rectum, uterus, gallbladder, upper stomach, kidneys, liver, ovaries, pancreas, thyroid, meningioma, and multiple myeloma. Do you have a tip on a science story that Newsweek should be covering? Do you have a question about appendiceal adenocarcinoma? Let us know via science@ Reference Holowatyj, A. N., Washington, M. K., Goldberg, R. M., & Murphy, C. C. (2025). Birth cohort effects in appendiceal adenocarcinoma incidence across the United States. Annals of Internal Medicine, 178(7).
The Onion
an hour ago
- The Onion
CDC Publishes Female Body Hair Guidelines
ATLANTA—Stressing that the rules were formulated for the safety of all Americans, the Centers for Disease Control and Prevention released new guidelines Thursday governing female body hair. 'Effective immediately, women nationwide are advised to remove all hair from arms, legs, underarms, and genital areas or suffer the legal consequences,' said CDC spokesperson Jamie Reardon, stressing that failure to comply with the newly issued weekly waxing schedule for women 18 and over would result in a $50 fine for every hair spotted that was over a millimeter long. 'Even so much as a thin landing strip or faint peach fuzz on the cheeks should be reported to authorities. That is, unless the woman in question has written approval from a male family member. But why would they do that? It's true that body hair doesn't cause diseases, per se. But it does look very gross.' This reportedly represents the first significant revisions to U.S. female body hair guidelines since 1977, when CDC director David Sencer urged all women to grow a full and unapologetic bush.
